ボシゥメンカトゥリン (Catherine Beauchemin) - マイポータル

基本情報

所属: 特定国立研究開発法人理化学研究所理化学研究所数理創造プログラム (iTHEMS) 副プログラムディレクター

連絡先: cbeauriken.jp
研究者番号: 70898931
ORCID iD: https://orcid.org/0000-0003-0599-0069
J-GLOBAL ID: 202001014673103615
Researcher ID: G-4619-2011
researchmap会員ID: R000011167

外部リンク: https://ithems.riken.jp/en/members/catherine-beauchemin

研究キーワード

経歴

2020年9月 - 現在

特定国立研究開発法人理化学研究所, 理化学研究所数理創造プログラム, 副プログラムディレクター

論文

Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays

Ankit Srivastava, Qinlu Wang, Christina D. Orrù, Manel Fernandez, Yaroslau Compta, Bernardino Ghetti, Gianluigi Zanusso, Wen-Quan Zou, Byron Caughey, Catherine A. A. Beauchemin

PLOS Pathogens 20(9) 2024年9月20日
Practical parameter identifiability and handling of censored data with Bayesian inference in mathematical tumour models

Jamie Porthiyas, Daniel Nussey, Catherine A. A. Beauchemin, Donald C. Warren, Christian Quirouette, Kathleen P. Wilkie

npj Systems Biology and Applications 2024年8月14日
Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1

Karen Y.Y. Fung, Tse Wing Winnie Ho, Zizhen Xu, Dante Neculai, Catherine A.A. Beauchemin, Warren L. Lee, Gregory D. Fairn

Journal of Lipid Research 2024年4月
Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses

Troy J. Kieran, Xiangjie Sun, Taronna R. Maines, Catherine A. A. Beauchemin, Jessica A. Belser

Journal of Virology 2024年2月20日
The effect of random virus failure following cell entry on infection outcome and the success of antiviral therapy

Christian Quirouette, Daniel Cresta, Jizhou Li, Kathleen P. Wilkie, Haozhao Liang, Catherine A. A. Beauchemin

Scientific Reports 13(1) 2023年10月11日
Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model

Hannah M. Creager, Troy J. Kieran, Hui Zeng, Xiangjie Sun, Joanna A. Pulit-Penaloza, Katie E. Holmes, Anders F. Johnson, Terrence M. Tumpey, Taronna R. Maines, Catherine A. A. Beauchemin …

Journal of Virology 2023年1月31日
Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample’s infection concentration

Daniel Cresta, Donald C. Warren, Christian Quirouette, Amanda P. Smith, Lindey C. Lane, Amber M. Smith, Catherine A. A. Beauchemin

PLOS Computational Biology 17(10) 2021年10月18日
The Maximum Energy of Shock-accelerated Electrons in a Microturbulent Magnetic Field

Donald C. Warren, Catherine A. A. Beauchemin, Maxim V. Barkov, Shigehiro Nagataki

The Astrophysical Journal 906(1) 33-33 2021年1月1日
Quantification of Ebola virus replication kinetics in vitro

Laura E. Liao, Jonathan Carruthers, Sophie J. Smither, Simon A. Weller, Diane Williamson, Thomas R. Laws, Isabel García-Dorival, Julian Hiscox, Benjamin P. Holder, Catherine A. A. Beauchemin …

PLOS Computational Biology 16(11) 2020年11月2日
A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

Christian Quirouette, Nada P. Younis, Micaela B. Reddy, Catherine A. A. Beauchemin

PLOS Computational Biology 16(4) 2020年4月13日
Quantifying mechanistic traits of influenza viral dynamics using in vitro data

Ada W.C. Yan, Jie Zhou, Catherine A.A. Beauchemin, Colin A. Russell, Wendy S. Barclay, Steven Riley

Epidemics 33 100406-100406 2020年
Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses

Catherine A. A. Beauchemin, Young-In Kim, Qin Yu, Giuseppe Ciaramella, John P. DeVincenzo

PLOS ONE 2019年4月15日
Progress and trends in mathematical modelling of influenza A virus infections

Catherine Beauchemin

Current Opinion in Systems Biology 2018年12月
Modelling endurance and resumption times for repetitive one-hand pushing

Rose, L.M., Beauchemin, C.A.A., Neumann, W.P.

Ergonomics 61(7) 2018年
Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms

Dobrovolny, H.M., Beauchemin, C.A.A.

PLoS ONE 12(7) 2017年
The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients

Palmer, J., Dobrovolny, H.M., Beauchemin, C.A.A.

Scientific Reports 7 2017年
Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors

Liao, L.E., Kowal, S., Cardenas, D.A., Beauchemin, C.A.A.

PLoS ONE 12(8) 2017年
Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy

Beauchemin, C.A.A., Miura, T., Iwami, S.

Scientific Reports 7 2017年
(In)validating experimentally derived knowledge about influenza A defective interfering particles

Liao, L.E., Iwami, S., Beauchemin, C.A.A.

Journal of the Royal Society Interface 13(124) 20160412-20160412 2016年11月30日
Viral factors in influenza pandemic risk assessment

Lipsitch, M., Barclay, W., Raman, R., Russell, C.J., Belser, J.A., Cobey, S., Kasson, P.M., Lloyd-Smith, J.O., Maurer-Stroh, S., Riley, S. …

eLife 5(NOVEMBER2016) 2016年11月11日

もっとみる

ボシゥメンカトゥリン

基本情報

研究キーワード

経歴

論文

メニュー

共著者の一覧